Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

43 publications

Funding

2 grantsView NIH portfolio on RePORTER ↗

Active

1 grant
  • MPI
    Dynamics of Immune Response in Irradiated Rectal Cancer
    National Cancer Institute · 2022–2027
    U54CA274291-05
Completed grants (1)
  • PI
    A Phase II Study to Test the Efficacy of AB928 (dual adenosine receptor antagonist) and AB122 (a PD1 checkpoint inhibitor) in combination with short course radiotherapy and consolidation chemotherapy for rectal cancer.
    Bristol-Myers Squibb Foundation INC · 2021–2023
    BMSF 215338-02

Clinical research

1 study

Active

1 study
  • PI
    The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer.
    NA · Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
    Rectal Cancer
    NCT05943210